AAAAAA

   
Results: 1-8 |
Results: 8

Authors: Terwogt, JMM Huinink, WWT Schellens, JHM Schot, M Mandjes, IAM Zurlo, MG Rocchetti, M Rosing, H Koopman, FJ Beijnen, JH
Citation: Jmm. Terwogt et al., Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel, ANTI-CANC D, 12(4), 2001, pp. 315-323

Authors: Terwogt, JMM Rosing, H Rocchetti, M Frigerio, E Fraier, D Koopman, FJ Schellens, JHM Huinink, WWT Beijnen, JH
Citation: Jmm. Terwogt et al., High-performance liquid chromatographic methods for the determination of anovel polymer-bound paclitaxel derivative and free paclitaxel in human plasma, J LIQ CHR R, 23(8), 2000, pp. 1233-1251

Authors: Terwogt, JMM van Tellingen, O Panday, VRN Huizing, MT Schellens, JHM Huinink, WWT Boschma, MUS Giaccone, G Veenhof, CHN Beijnen, JH
Citation: Jmm. Terwogt et al., Cremophor EL pharmacokinetics in a phase I study of paclitaxel (Taxol (R))and carboplatin in non-small cell lung cancer patients, ANTI-CANC D, 11(9), 2000, pp. 687-694

Authors: Terwogt, JMM Tibben, MM Welbank, H Schellens, JHM Beijnen, JH
Citation: Jmm. Terwogt et al., Validated method for the determination of platinum from a liposomal source(SPI-77) in human plasma using graphite furnace Zeeman atomic absorption spectrometry, FRESEN J AN, 366(3), 2000, pp. 298-302

Authors: Malingre, MM Terwogt, JMM Beijnen, JH Rosing, H Koopman, FJ van Tellingen, O Duchin, K Huinink, WWT Swart, M Lieverst, J Schellens, JHM
Citation: Mm. Malingre et al., Phase I and pharmacokinetic study of oral paclitaxel, J CL ONCOL, 18(12), 2000, pp. 2468-2475

Authors: Terwogt, JMM Malingre, MM Beijnen, JH Huinink, WWT Rosing, H Koopman, FJ van Tellingen, O Swart, M Schellens, JHM
Citation: Jmm. Terwogt et al., Coadministration of oral cyclosporin a enables oral therapy with paclitaxel, CLIN CANC R, 5(11), 1999, pp. 3379-3384

Authors: Terwogt, JMM Schellens, JHM Huinink, WWT Beijnen, JH
Citation: Jmm. Terwogt et al., Clinical pharmacology of anticancer agents in relation to formulations andadministration routes, CANC TR REV, 25(2), 1999, pp. 83-101

Authors: Terwogt, JMM Mandjes, IAM Sindermann, H Beijnen, JH Huinink, WWTB
Citation: Jmm. Terwogt et al., Phase II trial of topically applied miltefosine solution in patients with skin-metastasized breast cancer, BR J CANC, 79(7-8), 1999, pp. 1158-1161
Risultati: 1-8 |